Neurotensin: specific binding to synaptic membranes from rat brain. 1977

P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet

The binding of neurotensin to synaptic membranes from rat brain was studied at 24 degrees with the use of [3H]neurotensin. The binding was found to be highly specific, saturable, and reversible. Values for KD of 2 nM and 0.9 nM were derived from equilibrium and kinetic experiments, respectively. Virtually no degradation of neurotensin was observed in the incubation medium after exposure to synaptic membranes under the conditions of the binding studies. Competitive inhibition of [3H]neurotensin binding by partial sequences of neurotensin revealed that the addition of the residue arginine-8 to the neurotensin-(9-13)-pentapeptide increases about 500-fold the relative binding potency, whereas the remaining portion of the NH2-terminal region is mainly responsible for full pharmacological potency; the COOH-terminal leucyl residue is essential for binding.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013570 Synaptic Membranes Cell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters. Membrane, Synaptic,Membranes, Synaptic,Synaptic Membrane

Related Publications

P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
January 1976, Life sciences,
P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
August 1985, Neuropharmacology,
P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
June 1984, Brain research,
P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
January 1980, Birth defects original article series,
P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
March 1983, The Journal of biological chemistry,
P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
November 1978, Proceedings of the National Academy of Sciences of the United States of America,
P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
August 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience,
P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
August 1986, The Journal of biological chemistry,
P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
March 1994, The Journal of pharmacology and experimental therapeutics,
P Kitabgi, and R Carraway, and J Van Rietschoten, and C Granier, and J L Morgat, and A Menez, and S Leeman, and P Freychet
February 1991, Biochemical Society transactions,
Copied contents to your clipboard!